Min Cheol Kim, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 14155 North 83rd Avenue, Suite 1103, Peoria, AZ 85381 Phone: 480-495-6492 |
Ms. Debora Elena Garcia-zalisnak, M.D. Ophthalmology - Cornea and External Diseases Specialist Medicare: Accepting Medicare Assignments Practice Location: 13340 N 94th Dr, Peoria, AZ 85381 Phone: 623-977-8341 |
Dr. Chrysanne Rinderknecht, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 13340 N 94th Dr, Peoria, AZ 85381 Phone: 623-977-8341 Fax: 623-933-2952 |
Dr. Lisa Dianne Mihora, MD Ophthalmology - Ophthalmic Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 9151 W Thunderbird Rd # G104, Peoria, AZ 85381 Phone: 623-522-8687 Fax: 862-522-8683 |
Dr. Charles Joseph Hofer, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 13340 N 94th Dr, Peoria, AZ 85381 Phone: 623-972-1101 Fax: 623-933-2952 |
Dr. Parminderpal Singh, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9151 W Thunderbird Rd Ste G101, Peoria, AZ 85381 Phone: 623-974-4789 Fax: 623-974-4798 |
News Archive
A new study published in the Journal of Infectious Diseases found that immediate treatment initiation for HIV infection has improved since local and federal guidelines began to recommend universal treatment for all persons diagnosed with HIV, regardless of their disease stage.
Dyadic International, Inc. ("Dyadic") announced today that it has extended its collaboration with The Scripps Research Institute ("Scripps") by entering into an agreement with Scripps to re-annotate the genome of Dyadic's patented and proprietary C1 fungus ("C1").
Ohio Governor John Kasich on Wednesday signed a law that would prohibit abortion coverage from the state insurance exchange Ohio must create under the federal health care law. ... The law bans Ohio citizens from being able to purchase insurance through the exchange that includes abortion coverage, even if they pay for it with their own money, said Kellie Copeland, executive director of NARAL Pro-Choice Ohio, who criticized the bill.
Twice-yearly intravenous infusion with denosumab, a new targeted therapy to stop bone loss, increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer. The report from an international research study, the first to document reduced fracture risk in men receiving the hormone-blocking treatment, was published today in the print edition of the New England Journal of Medicine (NEJM). Both fundamental research on rank ligand (RANKL) in prostate cancer bone metastasis and other molecular factors involved in the denosumab study were supported at Massachusetts General Hospital with funding from the Prostate Cancer Foundation (PCF).
Heart disease affects men and women in different ways. In women, symptoms of burgeoning heart disease are often more insidious, but when a heart attack strikes, it is more lethal than it is in men. Roughly 25 percent of men will die within a year of their first heart attack, but among women, 38 percent will die. Women are twice as likely as men to have a second heart attack within 6 years of their first one, and women are twice as likely as men to die after bypass surgery.
› Verified 1 days ago